97 related articles for article (PubMed ID: 19614561)
1. Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma.
Zhao XF; Gartenhaus RB
Expert Opin Ther Targets; 2009 Sep; 13(9):1085-93. PubMed ID: 19614561
[TBL] [Abstract][Full Text] [Related]
2. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
[TBL] [Abstract][Full Text] [Related]
3. Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas.
Zhao XF; Zhao MY; Chai L; Kukuruga D; Tan M; Stass SA
Int J Clin Exp Pathol; 2013; 6(2):148-54. PubMed ID: 23330000
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
Wanner K; Hipp S; Oelsner M; Ringshausen I; Bogner C; Peschel C; Decker T
Br J Haematol; 2006 Sep; 134(5):475-84. PubMed ID: 16856892
[TBL] [Abstract][Full Text] [Related]
5. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
7. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
8. mTOR activity in AIDS-related diffuse large B-cell lymphoma.
Browne SH; Diaz-Perez JA; Preziosi M; King CC; Jones GA; Jain S; Sun X; Reid EG; VandenBerg S; Wang HY
PLoS One; 2017; 12(2):e0170771. PubMed ID: 28192480
[TBL] [Abstract][Full Text] [Related]
9. A two-step inactivation mechanism of Myt1 ensures CDK1/cyclin B activation and meiosis I entry.
Ruiz EJ; Vilar M; Nebreda AR
Curr Biol; 2010 Apr; 20(8):717-23. PubMed ID: 20362450
[TBL] [Abstract][Full Text] [Related]
10. FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation.
Shah SA; Potter MW; Ricciardi R; Perugini RA; Callery MP
J Surg Res; 2001 May; 97(2):123-30. PubMed ID: 11341787
[TBL] [Abstract][Full Text] [Related]
11. A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.
Palmer A; Gavin AC; Nebreda AR
EMBO J; 1998 Sep; 17(17):5037-47. PubMed ID: 9724639
[TBL] [Abstract][Full Text] [Related]
12. PF-04691502, a dual PI3K/mTOR inhibitor has potent pre-clinical activity by inducing apoptosis and G1 cell cycle arrest in aggressive B-cell non-Hodgkin lymphomas.
Chen D; Mao C; Zhou Y; Su Y; Liu S; Qi WQ
Int J Oncol; 2016 Jan; 48(1):253-60. PubMed ID: 26549638
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase.
Yoon IS; Chung JH; Hahm SH; Park MJ; Lee YR; Ko SI; Kang LW; Kim TS; Kim J; Han YS
BMB Rep; 2011 Aug; 44(8):529-34. PubMed ID: 21871177
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells.
Huang WW; Tsai SC; Peng SF; Lin MW; Chiang JH; Chiu YJ; Fushiya S; Tseng MT; Yang JS
Int J Oncol; 2013 Jun; 42(6):2069-77. PubMed ID: 23591552
[TBL] [Abstract][Full Text] [Related]
15. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
Faghiri Z; Bazan NG
Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
[TBL] [Abstract][Full Text] [Related]
16. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
Banerjee SK; Weston AP; Zoubine MN; Campbell DR; Cherian R
Am J Pathol; 2000 Jan; 156(1):217-25. PubMed ID: 10623670
[TBL] [Abstract][Full Text] [Related]
17. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the G2/M transition by p53.
Taylor WR; Stark GR
Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
